These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 8597534)

  • 21. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
    Lin CW; Robbins PD; Georgescu HI; Evans CH
    Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells.
    Smith LM; Birrer MJ; Stampfer MR; Brown PH
    Cancer Res; 1997 Jul; 57(14):3046-54. PubMed ID: 9230221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R; Beck WT
    Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
    Flick MB; Sapi E; Kacinski BM
    J Cell Biochem; 2002; 85(1):10-23. PubMed ID: 11891846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
    Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2.
    Andersson G; Påhlman S; Parrow V; Johansson I; Hammerling U
    Cell Growth Differ; 1994 Jan; 5(1):27-36. PubMed ID: 8123590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1.
    Bobrovnikova-Marjon EV; Marjon PL; Barbash O; Vander Jagt DL; Abcouwer SF
    Cancer Res; 2004 Jul; 64(14):4858-69. PubMed ID: 15256456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S; Brown PH; Birrer MJ
    Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
    Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance.
    Johnston SR; Lu B; Scott GK; Kushner PJ; Smith IE; Dowsett M; Benz CC
    Clin Cancer Res; 1999 Feb; 5(2):251-6. PubMed ID: 10037172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid.
    Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D
    Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.